1 BACKGROUND
============

Cardiovascular diseases are among the leading causes of death worldwide. In Hungary, they are responsible for more than 60,000 cases of death annually ([@b1-sjph-54-03-154]). Screening can help detect patients with a high cardiovascular risk. Screening itself may not be enough; patients should also be informed and taught how to lead a healthier lifestyle. It is also necessary to treat them and provide follow-up ([@b2-sjph-54-03-154]).

Over previous decades, a number of methods for cardiovascular risk evaluation have been developed. EuroSCORE is the most accepted system in Europe and in Hungary. The SCORE system predicts the probability of a patient's cardiovascular mortality within ten years ([@b3-sjph-54-03-154]).

National cardiovascular screening programs usually focus on the whole population within selected age-categories. An example of this is the UK government's recommended national strategy to screen all adults aged 40--74 for cardiovascular risks. However, the financial demand of cardiovascular screening is huge, therefore, it is essential to find the appropriate method to choose the target population. One way focuses on a probably high-risk population (for example, smokers, obese people, etc.), which is identified by different pre-screening methods, such as using questionnaires (e.g. the Findrisc-questionnaire), or the data of patients' medical records ([@b4-sjph-54-03-154]).

Screening for cardiovascular diseases is usually the task of general practitioners on the basis of definite protocols, and it is financed by health insurance agencies or governments. As an initiative, between 1999 and 2009, a government-financed managed care project was introduced and carried out in Hungary ([@b5-sjph-54-03-154]). A part of this project included complex screening programs to improve morbidity and mortality of the population of participating regions.

1.1 Aims
--------

-   The main scope of this paper is to describe the cardiovascular screening program which was organized in Bács-Kiskun County, Central-Eastern Hungary, including the implementation and the appraisal of the project.

Other goals:

-   Evaluation and comparison of the outcomes of the two different screening methods with a pre-screened and randomly selected population.

-   Comparison of practice-based and regional/national mortality data.

2 SUBJECTS AND METHODS
======================

2.1 Selection of Participants
-----------------------------

The managed health care system (MHCS) was introduced and applied in Hungary between 1999 and 2009. The gradually expanding system finally covered 22% of the population and included the full spectrum of curative-preventive health care. To join the MHCS, general practitioners had to submit an application to the National Health Insurance Fund Administration (NHIFA). If the NHIFA accepted it, the patients belonging to each general practitioner got into the system automatically. The main points of acceptance were the public health status of a given region of the country and the rate of risk adjusted quote of a given region. Other key persons of the MHCS were case managers, who were interested in the optimization of patient paths. Case managers accomplished a provider and financing function. Case managers of Bács-Kiskun County worked in Kecskemét.

As mentioned above, each case manager had to organize a complex public health prevention program. Our program, which focused on screening and preventing cardiovascular diseases, was started in Bács-Kiskun County involving 4,462 patients of 40 primary care practices. Between 2006 and 2009, participants were recruited from three different sites; the city of Kecskemét (county seat), and from smaller towns and villages of the neighbouring area.

2.2. Inclusion Criteria
-----------------------

General criteria: persons without any known cardiovascular disease and without any medication were applicable for both methods.

Pre-screened patients were selected from the following groups:

1.  \- Patients who have not visited their general practitioners for more than two years and whose medical history contained at least one of the following:

    -   male over 55 years of age,

    -   female over 65 years of age,

    -   cardiovascular event (acute myocardial infarction or stroke) in the family medical history,

    -   smoker,

    -   body mass index (BMI) \> 25 kg/m2 (measured during previous encounters).

Family doctors were authorized to involve randomly selected patients without any known cardiovascular disease and who did not meet the other specific criteria mentioned above.

2.3 Exclusion Criteria
----------------------

-   under 18 years of age,

-   pregnancy.

Patients who met the inclusion criteria were called in by mail.

2.4 Screening Procedures
------------------------

A data sheet was filled in with the following data:

-   personal medical history coded according to the International Classification of Diseases 10th version (ICD-10) ([@b6-sjph-54-03-154]),

-   cardiovascular diseases and/or diabetes mellitus in the family medical history,

-   questions about the patient's lifestyle: smoking, alcohol consumption, amount of physical activity,

-   anthropometric measurements (body height and weight, calculation of BMI, waist circumference),

-   laboratory tests (fasting blood glucose, triglyceride, total-cholesterol, high and low density lipoproteins, high sensitivity C-reactive protein (hs-CRP) level).

Special questions were focused on the eating habits of patients, applicable for the Hungarian circumstances.

Patients were asked to sign the Informed Consent Form.

2.5 Intervention
----------------

The intervention depended on patients' cardiovascular risk status, and it consisted of the following points:

-   if any cardiovascular disease or diabetes mellitus was diagnosed, the patient's family doctor started treating it on the basis of national guidelines,

-   high risk patients were initiated follow-ups based on the guidelines of the 5th Hungarian Cardiovascular Consensus Conference ([@b7-sjph-54-03-154]),

-   each patient received personal information about a healthy life style.

The patients' follow-ups were tailored by the above mentioned guidelines.

2.6 Mortality Data
------------------

After finishing the program, the benefits of screening for the local population were estimated by the comparison of the mortality data of participating family practices and the regional and national mortality trends based on the data of the national census of 2011 ([@b1-sjph-54-03-154]).

2.7 Informatics Support Available for the Program
-------------------------------------------------

An electronic medical sheet and a questionnaire about eating habits were integrated into general practitioners' computer program. Program users could download patients' laboratory results from the server of the central laboratory. SCORE points were calculated and recommended changes in lifestyle were generated by software for each patient, and a follow-up plan was established for medical teams on the basis of two data sources and current protocols.

2.8 Statistics
--------------

Before statistical data processing, the database was checked accurately. The questionable data were revised based on the participating general practitioners' databases, and were corrected or deleted. The outcome of the groups was compared with the Student's t-test, which required p values of less than 0.05.

Besides the crude mortality ratio (death/1000 people), standardized mortality ratios were calculated with regards to the number of observed deaths as opposed to the expected number of deaths in the given population. For calculating the expected number of deaths, we used Hungarian age- and gender-specific mortality data. The basic year was 2011.

2.9 Ethics
----------

The study was previously approved by the Regional Ethical Committee.

3 RESULTS
=========

3.1 Results of Cardiovascular Screening Program
-----------------------------------------------

### 3.1.1 Characteristics of Population

Altogether 4,462 patients were screened, 1,977 men and 2,485 women. The average age in total was 47.4 years (median: 49 years), 47.9 for men and 47.1 for women.

[Table 1](#t1-sjph-54-03-154){ref-type="table"} shows the distribution of the study population by gender, age, family medical history, BMI, presence of metabolic syndrome ([@b8-sjph-54-03-154]), alcohol consumption, regular physical activity and smoking. The anthropometric characteristics of the sample and the results of laboratory tests are presented in [Table 2](#t2-sjph-54-03-154){ref-type="table"}.

### 3.1.2 SCORE Risk Assessment

[Table 3](#t3-sjph-54-03-154){ref-type="table"} shows the distribution of the screened patients on the basis of SCORE assessment.

266 patients were classified into high cardiovascular risk group on the basis of SCORE assessment (cardiovascular risk 5% or more). There were more men (252) in the high risk group than women ([@b14-sjph-54-03-154]).

A further 78 patients with cardiovascular risk below 5% can be assessed into the high cardiovascular risk group: 3 patients' total cholesterol level was more than 8 mmol/l, one patient's systolic blood pressure was higher than 180 mmHg, 66 patients were seriously obese (BMI\>40 kg/m2) and 9 patients had early cardiovascular event in their family medical history.

3.2 Results of the Modelling to Differentiate the Efficacy of the Two Screening Models (Population Based vs. Pre-Screened)
--------------------------------------------------------------------------------------------------------------------------

3,420 patients (1,518 men and 1,902 women) were initiated to the study of the pre-screened group. The second group (1,042 patients) was initiated randomly. [Table 4](#t4-sjph-54-03-154){ref-type="table"}. shows the main characteristics of the two groups.

The mean SCORE point was 1.82 in the pre-screened group and 0.55 in the random screened group (difference: 1.27, p\< 0,001). The distribution of the two groups of patients was different based on SCORE categories. Most of the patients in the randomly screened population belonged to the low risk categories and only three (0.29%) high risk patients were found. However, there were 274 (8.0%) high risk patients in the pre-screened population. [Table 5](#t5-sjph-54-03-154){ref-type="table"} shows in details the distribution of the two groups on the basis of SCORE points.

3.3 Retrospective Aggregate Mortality Data
------------------------------------------

Aggregated mortality data were collected from the practices after the program had been completed. The average follow-up was 7.15 years. Data contain all causes of mortality and cardiovascular mortality separately.

We had information on 4,182 patients of the 4,461 screened patients. The total number of deaths: 158, mortality 5.7 %° (national: 12.0), cardiovascular death: 46 patients, 1.3 %° (national: 6.4). [Table 6](#t6-sjph-54-03-154){ref-type="table"} shows mortality data divided by participating settlements.

4 DISCUSSION
============

Besides participation in the primary prevention, screening as secondary prevention is an important requirement for primary care services ([@b10-sjph-54-03-154]--[@b12-sjph-54-03-154]). Opportunistic screening is usually conducted in the daily practice, while programmes for screening the whole population require comprehensive governmental or public health support, including financial coverage ([@b13-sjph-54-03-154]).

The Hungarian government decided to launch a program (Managed Care System), in which participating general practitioners were authorized to follow up their patients at the other two levels of the health care system (outpatient's services, provided by specialists, and inpatient services delivered in hospitals). The description of this wider context of collaboration was beyond the scope of this paper. One of the goals of the managed care system of the NHIFA between 1999 and 2009 was that health case managers were expected to organize public health programs for their patients ([@b14-sjph-54-03-154]). Within the framework of the Managed Care System we focused on screening for cardiovascular diseases in Kecskemét and its region. Our main aim was to identify patients who had high risk for a cardiovascular disease without any symptoms. We can say, based on our results, that the basis of an effective cardiovascular prevention should be a well-organized, controlled and sufficiently funded screening programme.

Risk score assessments can help us to identify high risk patients, but we have to conduct numerous examinations with negative results to identify the patients at high risk ([@b15-sjph-54-03-154]). We compared the outcomes of the pre-screened and randomly screened population in terms of the achieved average risk points. The average scores were significantly higher in the case of the 'pre-screening approach.' We found many more high risk patients in the pre-screened group compared with the randomly screened population (17.4 versus 0.6%), which means that, following the opportunistic screening method, we should screen roughly ten times more people to get similar results.

Mortality was significantly lower in the participating primary care practices than expected on the basis of national mortality data.

4.1 Limitation
--------------

Unfortunately, we were unable to assess cardiovascular morbidity and mortality more precisely, because the program budget did not allow a longer follow-up period. The data presented in this paper only predict trends without statistical significance and individual follow up.

We concluded that the screening for cardiovascular diseases can find patients with high risk in an early phase. While screening programs focus on whole populations, only a few individuals will benefit from them, so we should narrow the target population by using pre-screening on the basis of the main risk factors. The tight follow-up of patients can reduce the mortality among the screened population.

Many thanks the program coordinator team members, GáborVarga, Andrea Preiszinger and Katalin Faragó, and to all family physicians participating in the program.
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###### 

Distribution of the study population by gender, age, family medical history, BMI, metabolic syndrome, alcohol consumption, regular physical activity and smoking.

                                                                               Men     Women            
  ---------------------------------------------------------------------------- ------- -------- ------- --------
  Gender                                                                       1,977   *44.3*   2,485   *56.7*
  Distribution of age-groups                                                                            
  w18--19 \[year\]                                                             9       *0.5*    19      *0.8*
  20--29                                                                       121     *6.1*    205     *8.3*
  30--39                                                                       259     *13.1*   337     *13.6*
  40--49                                                                       653     *33.1*   771     *31.1*
  50--59                                                                       666     *33.7*   813     *32.8*
  60--69                                                                       266     *13.5*   335     *13.5*
  70--80                                                                       2       *0.1*    2       *0.8*
  Family medical history                                                                                
  Acute myocardial infarction                                                  17      *0.8*    24      *0.9*
  Stroke                                                                       5       *0.2*    7       *0.2*
  BMI categories\[kg/m2\]                                                                               
  Underweight (BMI\<18.5)                                                      9       *0.5*    47      *1.9*
  Normal (BMI:18.5--24.9)                                                      481     *24.3*   987     *39.8*
  Overweight (BMI: 25--29.9)                                                   904     *45.8*   863     *34.8*
  Obese (BMI:30--39.9)                                                         534     *27.0*   522     *21.0*
  severe obese (BMI\>40)                                                       48      *2.4*    63      *2.5*
  Metabolic syndrome                                                           389     *19.7*   467     *18.8*
  Alcohol consumption[\*](#tfn1-sjph-54-03-154){ref-type="table-fn"}           895     *45*     253     *10*
  Regular physical activity[\*\*](#tfn2-sjph-54-03-154){ref-type="table-fn"}   648     *32*     730     *29*
  Smokers                                                                      395     *20*     266     *10.7*

women: more than 2 dl beer or 1 dl wine or 3 cl spirits/day, men: more than 5 dl beer or 2 dl wine or 3 cl spirits/day

weekly at least 3 × 30 min. dynamic sport activity

###### 

Results of anthropometric measurements and laboratory tests.

  Anthropometric Men and laboratory data   Men     Women   All                    
  ---------------------------------------- ------- ------- ------- ------ ------- ------
  Diastolic Blood pressure \[Hgmm\]        83.1    19.5    81.4    28.3   82.2    24.8
  Systolic Blood pressure \[Hgmm\]         133.8   16.4    128.4   16.4   130.8   16.6
  Total serum cholesterol \[mmol/l\]       5.5     1.3     5.5     2.1    5.5     1.8
  High density lipoprotein \[mmol/l\]      1.5     0.4     1.7     4.5    1.6     3.4
  Triglyceride \[mmol/l\]                  2.0     5.8     1.4     0.9    1.7     3.9
  Fasting blood glucose \[mmol/l\]         5.4     1.3     5.1     1.0    5.2     1.2
  hs-CRP \[mg/l\]                          4.2     7.7     4.1     0.1    4.2     7.6
  Weight \[kg\]                            85.5    16.4    71.6    15.4   77.8    17.3
  Waist circumference \[cm\]               99.1    15.3    91.8    33.9   95.0    13.5

The appraisal of patients with high cardiovascular risk was based on the criteria of the 5th Hungarian Cardiovascular Consensus Conference ([@b7-sjph-54-03-154]).

###### 

Patients' distribution on basis of SCORE assessment.

  SCORE categories   men   \%     women   \%     total   \%
  ------------------ ----- ------ ------- ------ ------- ------
  \<1%               493   24.9   1,556   62.7   2049    46.0
  1%                 637   32.2   619     24.9   1256    28.0
  2%                 269   13.6   221     8.9    490     11.0
  3--4%              326   16.5   72      2.9    398     8.9
  5--9%              227   11.5   14      0.6    241     5.4
  10--14%            21    1.1    0       0      21      0.5
  \>15%              4     0.2    0       0      4       0.1

###### 

Characteristics of the two screening model groups by gender, number, age, anthropometric, and laboratory data.

                                      Pre-screened group mean(SD)   Randomly initiated group   p value    Pre-screened group mean(SD)   Randomly initiated group   p value
  ----------------------------------- ----------------------------- -------------------------- ---------- ----------------------------- -------------------------- ----------
  N                                   1.528                         465                                   1.902                         577                        
  age \[year\]                        48.9 (9.8)                    40.9 (9.6)                 \< 0.001   53.6 (11.3)                   45.5 (10.2)                \< 0.001
  diastolic blood pressure \[mmHg\]   83.1(8.9)                     83.3(47.9)                 0.846      81.8 (33.7)                   81.3 (27.0)                0.432
  systolic blood pressure \[mmHg\]    135.0 (16.5)                  126.4 (13.3)               \< 0.001   132.0 (17.6)                  127.5 (15.9)               \< 0.001
  cholesterol \[mmol/l\]              5.6 (1.4)                     5.1 (1.1)                  \< 0.001   5.7 (1.1)                     5.5 (2.3)                  \< 0.001
  HDL \[mmol/l\]                      1.5 (0.4)                     1.5 (0.5)                  0.34       1.6 (0.4)                     1.7 (0.5)                  0.18
  triglicerid \[mmol/l\]              2.1(6.2)                      1.5 (1.4)                  0.112      1.6 (0.9)                     1.4 (0.8)                  0.088
  blood glucose \[mmol/l\]            5.4 (0.7)                     5.1 (0.7)                  \< 0.001   5.2 (0.8)                     5.1 (1.0)                  \< 0.001
  hs-CRP \[mg/l\]                     4.3 (1.3)                     3.4 (5.8)                  0.07       4.3 (1.0)                     4.1 (1.0)                  0.173
  weight \[kg\]                       87.5 (8.0)                    72.5 (15.7)                \< 0.001   73.6 (14.6)                   71.1 (15.6)                \< 0.001
  waist circumference \[cm\]          100.9 (13.0)                  87.7 (10.7)                \< 0.001   94.0 (15.7)                   91.2 15.2)                 0.189
  LDL-cholesterol \[mmol/l\]          3.1 (1.22)                    2.9 (0.9)                  =0.001     3.2 (1.0)                     3.0 (1.1)                  \< 0.001
  BMI \[kg/m2\]                       28.9 (4.6)                    23.1 (1.6)                 \< 0.001   28.0 (5.4)                    26.5(5.2)                  0.049

###### 

Distribution of pre-screened and random initiated groups on basis of SCORE categories.

  SCORE categories   Pre-screened group   Random initiated group                                       
  ------------------ -------------------- ------------------------ ----- -------- ----- -------- ----- --------
  \<1%               295                  *19.4*                   622   *32.7*   281   *60.4*   404   *70.0*
  1%                 496                  *32.7*                   398   *21.0*   137   *29.5*   150   *26.0*
  2%                 218                  *14.4*                   595   *31.3*   40    *8.6*    19    *3.3*
  3--4%              286                  *18.8*                   236   *12.4*   5     *1.1*    3     *0.5*
  5--9%              200                  *13.2*                   51    *2.7*    2     *0.4*    1     *0.2*
  10--14%            19                   *1.2*                    0     *0*      0     *0*      0     *0*
  \>15%              4                    *0.3*                    0     *0*      0     *0*      0     *0*

###### 

Comparison of the mortality data of participating settlements and participating practices.

                   General           Participating practices          Cardiovascular mortality           Participating practices   
  ---------------- --------- ------- ------------------------- ------ -------------------------- ------- ------------------------- ------
  Hungary          12.0      100.0   \-                        \-     6.9                        100     \-                        \-
  Kecske-mét       11.0      63.9    3.4                       22.2   5.3                        47.3    1.4                       27.0
  Lajosmi-zse      15.2      94.2    3.6                       23.3   7.7                        80.1    0.7                       14.0
  Kiskőrös         14.0      81.4    4.5                       24.0   6.7                        76.7    1.6                       33.4
  Szabad-szállás   17.3      100.7   3.0                       19.4   8.6                        88.4    0.0                       0.0
  Balló-szög       14.9      86.6    6.9                       45.0   6.2                        36.8    2.0                       39.4
  Harta            15.8      91.8    5.4                       35.0   7.9                        81.6    1.5                       30.6
  Tiszaal-pár      19.3      112.3   13.3                      87.2   9.8                        104.0   2.4                       47.8
  Fülöphá-za       14.6      84.9    3.2                       25.8   6.1                        57.1    1.6                       31.2
  Helvécia         16.2      94.2    7.9                       50.0   3.6                        49.7    0.0                       0.0
  All practices    \-        \-      5.7                       32     \-                         \-      1.3                       28.8

SMR: standardised mortality ratio. SMR was calculated based on Hungarian sex- and age-specific mortality rates in 2011 ([@b9-sjph-54-03-154]).
